270
Views
2
CrossRef citations to date
0
Altmetric
Brief Review

Simplifying anemia management in hemodialysis patients: ESAs administered at longer dosing intervals can enhance opportunities to provide patient-focused care

&
Pages 1539-1550 | Accepted 11 May 2011, Published online: 17 Jun 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

J. Mark Stephens, Larry C. Emerson, Leslie A. Spry, John P. Caloyeras, Ernest R. Anderson, John F. Reitan & Akhtar Ashfaq. (2016) Time savings of weekly versus three-times-per-week administration of erythropoiesis stimulating agents in United States dialysis patients. Current Medical Research and Opinion 32:2, pages 313-320.
Read now

Articles from other publishers (1)

Juan José Pérez-RuixoMercedes Cucala-Ramos, Ester García-Gonzalo, Beatriz Del Val Romero & Neus Valveny. (2013) Between subjects variability in haemoglobin and dose are not associated with the erythropoiesis-stimulating agent used to treat anaemia in dialysis: a meta-analysis. British Journal of Clinical Pharmacology 75:1, pages 15-25.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.